Immutable evidence record · ticker

Telomir Pharmaceuticals, Inc. Common Stock (TELO)

Published as observed on 16 August 2026 at 03:55 BST.

Telomir Pharmaceuticals, Inc. Common Stock has a balanced company news read. Its latest completed weekly trend is negative.

As of
16 Aug 2026, 03:55
Scope
company and instrument
Evidence
17 items
Independent sources
2
Country
United States
Sector
Healthcare
Previous read
50.000
Change

Verification

Evidence links

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, Telomir Pharmaceuticals, Inc. Common Stock (TELO), 2026-08-16, https://sharemaestro.com/evidence/487eb0c0-398f-4bf9-a438-38dd1421bd45/
Record checksum 81f68386cefedbbf03592a39d2c5a0e112b418145625f71e1b8b88c7500f441c

Evidence context